Cangrelor to Clopidogrel or Prasugrel Transition Study

NCT01979445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: Cangrelor
DRUG: Clopidogrel
DRUG: Prasugrel

Sponsor

The Medicines Company